Leukemia Research
Volume 24, Issue 4 , Pages 281-288 , April 2000

Etoposide-induced apoptosis is not associated with the Fas pathway in acute myeloblastic leukemia cells

  • Timo Siitonen

      Affiliations

    • Department of Internal Medicine, University of Oulu, Kajaanintie 50, FIN-90220 Oulu, Finland
    • ,
  • Pentti Mäntymaa

      Affiliations

    • Department of Clinical Chemistry, University of Oulu, Kajaanintie 50, FIN-90220 Oulu, Finland
    • ,
  • Marjaana Säily

      Affiliations

    • Department of Internal Medicine, University of Oulu, Kajaanintie 50, FIN-90220 Oulu, Finland
    • ,
  • Eeva-Riitta Savolainen

      Affiliations

    • Department of Clinical Chemistry, University of Oulu, Kajaanintie 50, FIN-90220 Oulu, Finland
    • ,
  • Pirjo Koistinen

      Affiliations

    • Department of Internal Medicine, University of Oulu, Kajaanintie 50, FIN-90220 Oulu, Finland
    • Corresponding Author InformationCorresponding author. Tel.: +358-8-3152011; fax: +358-8-3154139

Received 25 April 1999 ,Revised 13 November 1999

References 

  1. Kaufmann SH, Desnoyers S, Ottaviano Y, Davidson NE, Poirier GG. Specific proteolytic cleavage of poly(ADPribose) polymerase: an early marker of chemotherapy-induced apoptosis. Cancer Res. 1993;53:3976
  2. Lazebnik YA, Kaufmann SH, Desnoyers S, Poirier GG, Earnshaw WC. Cleavage of poly(ADPribose)polymerase by a proteinase with properties like ICE. Nature. 1994;371:346
  3. Martins LM, Kottke T, Mesner PW, Basi GS, Sinha S, Frigon Jr N, et al.  Activation of multiple interleukin-1 beta converting enzyme homologues in cytosol and nuclei of HL-60 cells during etoposide-induced apoptosis. J. Biol. Chem. 1997;272:7421
  4. Perkins C, Kim CN, Fang G, Bhalla KN. Overexpression of Apaf-1 promotes apoptosis of untreated and paclitaxel- or etoposide-treated HL-60 cells. Cancer Res. 1998;58:4561
  5. Schulze-Osthoff K, Ferrari D, Los M, Wesselborg S, Peter ME. Apoptosis signaling by death receptors. Eur. J. Biochem. 1998;254:439
  6. Itoh N, Yonehara SIA, Yonehara M, Mizushima S, Sameshima M, Hase A, et al. The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis. Cell. 1991;66:233
  7. Oehm A, Behrmann I, Falk W, Pawlita M, Maier G, Klas C, et al. Purification and molecular cloning of the APO-1 cell surface antigen, a member of the tumor necrosis/nerve growth factor receptor superfamily. Sequence identity with the Fas antigen. J. Biol. Chem. 1992;267:10709
  8. Nagata S, Goldstein P. The Fas death factor. Science. 1995;267:1449
  9. Friesen C, Herr I, Krammer PH, Debatin K-M. Involvement of the CD95 (APO-1/Fas) receptor/ligand system in drug-induced apoptosis in leukemia cells. Nature Med. 1996;2:574
  10. Micheau O, Solary E, Hammann A, Martin F, Dimanche-Boitrel M-T. Sensitization of cancer cells treated with cytotoxic drugs to Fas-mediated cytotoxity. JNCI. 1997;89:783
  11. Mizutani Y, Okada Y, Yoshida O, Fukumoto M, Bonavida B. Doxorubicin sensitizes human bladder carcinoma cells to Fas-mediated cytotoxity. Cancer. 1997;79:1180
  12. Müller M, Strand S, Hug H, Heinemann EM, Walczak H, Hofmann WJ, et al. Drug-induced apoptosis in hepatoma cells is mediated by the CD95 (APO-1/Fas) receptor/ligand system and involves activation of wild-type p53. J. Clin. Invest. 1997;99:403
  13. Nakamura S, Takeshima M, Nakamura Y, Ohtake S, Matsuda T. Induction of apoptosis in HL60 leukemic cells by anticancer drugs in combination with anti-Fas monoclonal antibody. Anticancer Res. 1997;17:173–180
  14. Fulda S, Sieverts H, Friesen C, Herr I, Debtin K-M. The CD95 (APO-1/Fas) system mediates drug-induced apoptosis in neuroblastoma cells. Cancer Res. 1997;57:3823
  15. McGahon AJ, Costa Pereira AP, Daly L, Cotter TG. Chemotherapeutic drug-induced apoptosis in human leukaemic cells is independent of the Fas (APO-1/CD95) receptor/ligand system. Br. J. Haematol. 1998;101:539
  16. Komada Y, Zhou Y-W, Zhang X-L, Xue H-L, Sakai H, Tanaka S, et al. Fas receptor (CD95)-mediated apoptosis is induced in leukemic cells entering G1B compartment of the cell cycle. Blood. 1995;86:3848
  17. Min YH, Lee S, Lee JW, Chong SY, Hahn JS, Ko YW. Expression of Fas antigen in acute myeloid leukemia is associated with therapeutic response to chemotherapy. Br. J. Haematol. 1996;93:928
  18. Iijima N, Miyamura K, Itou T, Tanimoto M, Sobue R, Saito H. Functional expression of Fas (CD95) in acute myeloid leukemia cells in the context of CD34 and CD38 expression: Possible correlation with sensitivity to chemotherapy. Blood. 1997;90:4901
  19. Dirks W, Schöne S, Uphoff C, Quentmeier H, Pradella S, Drexler HG. Expression and function of CD95 (Fas/APO-1) in leukaemia-lymphoma tumor lines. Br. J. Haematol. 1997;96:584
  20. Siitonen T, Alaruikka P, Mántaymaa P, Savolainen ER, Kavanagh TJ, Kvejsa CM, et al. Protection of acute myeloblastic leukemia cells against apoptotic cell death by high glutathione and gamma-glutamyl-cysteine synthesase levels during etoposide-induced oxidative stress. Ann. Oncol. 1999;10:1361
  21. Hainsworth JD, Greco FA. Etoposide: twenty years later. Ann. Oncol. 1995;6:327
  22. Zheng A, Mäntymaa P, Säily M, Siitonen T, Savolainen E-R, Koistinen P. Apoptosis induced by all-trans retinoic acid associates with down-regulation of bcl-2 and changes in mitochondrial function in acute leukaemia cells. Br. J. Haematol. 1999;105:215
  23. Takahashi T, Tanaka M, Inazawa J, Abe T, Suda T, Nagata S. Human Fas ligand: gene structure, chromosomal location and species specificity. Int. Immunol. 1994;6:1567
  24. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 1987;162:156
  25. Kaufmann SH. Induction of endonucleolytic DNA cleavage in human acute myelogenous leukemia cells by etoposide, camphothecin and other cytotoxic anticancer drugs: a cautionary note. Cancer Res. 1989;49:5870
  26. Wakahara Y, Nawa A, Okamoto T, Hayakawa A, Kikkawa F, Suganama N, et al.  Combination effect of anti-Fas antibody and chemotherapeutic drugs in ovarian cancer cells in vitro. Oncology. 1997;54:48
  27. Friesen C, Fulda S, Debtin KM. Deficient activation of the CD95 (APO-1/Fas) system in drug-resistant cells. Leukemia. 1997;11:1833
  28. Eischen CM, Kottke TJ, Martins LM, Basi GS, Tung JS, Earnshaw WC, et al. Comparison of apoptosis in wild-type and Fas-resistent cells: chemotherapy-induced apoptosis is not dependent on Fas/Fas ligand interactions. Blood. 1997;90:935
  29. Gamen S, Anel A, Lasierra P, Alava MA, Martinez Lorenzo MJ, Pineiro A, et al. Doxorubisin-induced apoptosis in human T-cell leukemia is mediated by caspase-3 activation in a Fas-independent way. FEBS Lett. 1997;417:360
  30. Villunger A, Egle A, Kos M, Hartmann BL, Geley S, Kofler R, et al. Drug-induced apoptosis is associated with enhanced Fas (Apo-1/CD95) ligand expression but occurs independently of Fas (Apo-1/CD95) signalling in human T-acute lymphatic leukemia cells. Cancer Res. 1997;57:3331
  31. Handle KR. Etoposide pharmacology. Seminars Oncol. 1992;19:3
  32. Landowski TH, Qu N, Buyuksal I, Painter JS, Dalton WS. Mutations in Fas antigen in patients with multiple myeloma. Blood. 1997;90:4266
  33. Beltinger C, Kurz E, Böhler T, Schrappe M, Ludwig W-D, Debatin K-M. CD95 (APO-1/Fas) mutations in childhood T-lineage acute lymphoblastic leukemia. Blood. 1998;91:3943
  34. Owen-Schaub LB, Radinsky R, Kurzel E, Berry K, Yonehara S. Anti-Fas on nonhematopoietic tumors: levels of Fas/APO-1 and bcl-2 are not predictive of biological responsiveness. Cancer Res. 1994;54:1580
  35. Natoli G, Ianni A, Costanzo A, De Petrillo G, Ilari I, Chirillo P, et al. Resistance to Fas-mediated apoptosis in human hepatoma cells. Oncogene. 1995;11:1157
  36. Takenaka K, Nagafuji K, Harada M, Mizuno S, Miyamoto T, Makino S, et al. In vitro expression of hematopoietic progenitor cells induces functional expression of Fas antigen (CD95). Blood. 1996;88:2871
  37. Nagafuji K, Shibuya T, Harada M, Mizuno S, Takenaka K, Miyamoto T, et al. Functional expression of Fas antigen (CD95) on hematopoietic progenitor cells. Blood. 1995;86:883

PII: S0145-2126(99)00176-9

Leukemia Research
Volume 24, Issue 4 , Pages 281-288 , April 2000

Article Tools

* Image Usage & Resolution